Search clinical trials for: Extended-spectrum β-lactamases (ESBLs)

Total 13 results

Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Antibiotic Utilization Measures and Control of Extended-Spectrum-Lactamases (ESBLs)

Bacterial Infection
Pfizer

Completed

Assessing Prevalence Of Beta Lactamase Production From Clinical Isolates Of Hospitalized Patients And Comparison Of Antibiotic Susceptibility Patterns (EGAST 2008)

Infection

India
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study of Antibiotic Utilization Measures and Control of ESBLs in China

ICU Patient
Fundación Pública Andaluza para la gestión de la...
Spanish Network for Research in Infectious Diseases

Completed

Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.Coli (FOREST)

Infection Due to ESBL Escherichia Coli

Spain
National Taiwan University Hospital

Completed

The Prevalence of Extend-Spectrum β-Lactamase (ESBL) Producing Isolates Among Common Enterobacteriaceae in Taiwan

Enterobacteriaceae Infections

Taiwan
Western Galilee Hospital-Nahariya

Recruiting

Extended-spectrum β-lactamase -Producing Enterobacteriaceae (ESBL) Vertical Transmission in Women With Preterm Labor Versus Those in Term Pregnancy

Preterm Labor

Israel
Khon Kaen University

Recruiting

Sitafloxacin and Ertapenem Treatment for Acute Urinary Tract Infection Caused by E. Coli or K. Pneumoniae in Post-kidney Transplantation Patients

Urinary Tract Infections | Kidney Transplantation | Klebsiella Infections | Escherichia Coli Infections | Anti-Infective Agents, Urinary

Thailand
Assistance Publique - Hôpitaux de Paris

Completed

Temocillin in ESBL-Enterobacteriaceae Infections (TMO2016)

Infectious Disease

France
Fouad Madhi

Completed

Urinary Tract Infection Due to Beta-lactamase-producing Enterobacteriaceae in Children (PYELOBLSE)

Urinary Tract Infections

France
University Hospital, Angers

Unknown

Factors Influencing the Fecal Relative Abundance of ESBL-producing Enterobacteriaceae in Intensive Care (BLSE-REA).

ESBL-producing Enterobacteriaceae Infections
Spanish Network for Research in Infectious Diseases
European Society of Clinical Microbiology and Infectious Diseases

Completed

Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study. (INCREMENT-SOT)

Pathologic Processes | Sepsis | Systemic Inflammatory Response Syndrome | Inflammation | Bacterial Infections | Bacteremia | Infection | Organ Transplantation | Clinically Significant Bacteremia

Spain
Central Hospital, Nancy, France

Terminated

Evaluation of the Non-inferiority of Cefoxitin Versus Imipenem/Cilastatin in the Treatment of Urinary Tract Infections Caused by ESBL-producing Escherichia Coli (COLIFOX)

Urinary Tract Infections

France
University Hospital, Clermont-Ferrand
University Hospital, Estaing; Hopital Gabriel Montpied

Unknown

Assessment of the Prevalence of Extended-Spectrum Betalactamase Producing Enterobacteriaceae Among ICU Staff (REASSE)

Antibiotic Resistance | Extended-spectrum Betalactamase | Enterobacteriaceae | Escherichia Coli

France

3

Subscribe